feed,title,long_url,short_url
Benzinga,"Novo Nordisk Halts Late-Stage Study Of Experimental Hypertension Drug, Takes Over $800M Impairment Charge",https://benzinga.com/general/biotech/24/06/39509637/novo-nordisk-halts-late-stage-study-of-experimental-hypertension-drug-takes-over-800m-impairment-,https://da.gd/NXEZQ
